Healthcare & Life Sciences
Peloton Therapeutics
United Statespelotontherapeutics.com
aliveseries-c-plus
series-c-plus
Stage
1
Investors
About
Peloton Therapeutics is a clinical stage pharmaceutical company developing first-in-class small molecule medicines targeting the transcription factor HIF-2α to treat cancer and other serious diseases by modulating previously undruggable protein-protein interactions.
Explore Peloton Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.